{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:01:12Z","timestamp":1792144872608,"version":"4.4.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":515,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"German Federal Ministry of Research and Education","award":["01EO1002 and 13GW0096D"],"award-info":[{"award-number":["01EO1002 and 13GW0096D"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1093\/annonc\/mdy117","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T06:40:17Z","timestamp":1524465617000},"page":"1354-1365","source":"Crossref","is-referenced-by-count":104,"title":["Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors\u2014Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)"],"prefix":"10.1016","volume":"29","author":[{"given":"C.T.","family":"Rieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mellinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Buchheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Egerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hentrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sandherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Silling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.G.T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"von Lilienfeld-Toal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-2564","authenticated-orcid":false,"given":"N.","family":"Lehners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdy117_bb0010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s005200050196","article-title":"Tetanus immunity in patients with hematological malignancies","volume":"6","author":"Hamarstrom","year":"1998","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.mph.0000163214.37147.5a","article-title":"Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia","volume":"27","author":"Ercan","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/08880018.2013.877111","article-title":"Assessment of immune response following immunization with DTP\/Td and MMR vaccines in children treated for acute lymphoblastic leukemia","volume":"31","author":"Koochakzadeh","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1542\/peds.67.2.222","article-title":"Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy","volume":"67","author":"van der Does-van den Berg","year":"1981","journal-title":"Pediatrics"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1086\/513648","article-title":"Influenza among hospitalized adults with leukemia","volume":"24","author":"Yousuf","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/tid.12054","article-title":"European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN","volume":"15","author":"Engelhard","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00368891","article-title":"Epidemiology of influenza A virus infection in patients with acute or chronic leukemia","volume":"3","author":"Elting","year":"1995","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/187152611794407818","article-title":"Epidemiology, prevention, and management of influenza in patients with hematologic malignancy","volume":"11","author":"Ison","year":"2011","journal-title":"Infect Disord Drug Targets"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0055","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2009-11-255455","article-title":"How I treat influenza in patients with hematologic malignancies","volume":"115","author":"Casper","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0060","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/pbc.22421","article-title":"Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy","volume":"54","author":"Shahgholi","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pbc.10459","article-title":"Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia","volume":"42","author":"Porter","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"27","key":"10.1093\/annonc\/mdy117_bb0075","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.vaccine.2016.04.053","article-title":"Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection","volume":"34","author":"Hakim","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/173.1.256","article-title":"Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease","volume":"173","author":"Chan","year":"1996","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0085","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1086\/523583","article-title":"A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients","volume":"45","author":"Kumar","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Rr-2","key":"10.1093\/annonc\/mdy117_bb0090","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0095","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/infdis\/161.5.926","article-title":"Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine","volume":"161","author":"Feldman","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1093\/annonc\/mdy117_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2012.03971.x","article-title":"Vaccination of immunocompromised patients","volume":"18","author":"Ljungman","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1093\/annonc\/mdy117_bb0105","unstructured":"Recommendation of the St\u00e4ndige Impfkommission (STIKO), Robert Koch-Insitut. 2016; http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2016\/Ausgaben\/34_16.pdf?__blob=publicationFile."},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2893.2006.00822.x","article-title":"Predictors of immunity after hepatitis A vaccination in HIV-infected persons","volume":"14","author":"Overton","year":"2007","journal-title":"J Viral Hepat"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0115","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","article-title":"Antiviral prophylaxis in patients with solid tumours and haematological malignancies\u2014update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)","volume":"94","author":"Sandherr","year":"2015","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0145-2126(97)00155-0","article-title":"Hepatitis B vaccination in acute lymphoblastic leukemia","volume":"22","author":"Goyal","year":"1998","journal-title":"Leuk Res"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0125","first-page":"27","article-title":"Vaccine prophylaxis of viral hepatitis B in patients with acute leukemia","volume":"80","author":"Gurina","year":"2008","journal-title":"Ter Arkh"},{"issue":"11","key":"10.1093\/annonc\/mdy117_bb0130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0145-2126(02)00044-9","article-title":"Passive active prophylaxis against Hepatitis B in children with acute lymphoblastic leukemia","volume":"26","author":"Somjee","year":"2002","journal-title":"Leuk Res"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0135","first-page":"105","article-title":"Rabies vaccination in a pediatric patient with acute myeloid leukemia during the course of chemotherapy: a case report","volume":"7","author":"Wiwanitkit","year":"2014","journal-title":"Iran J Cancer Prev"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0140","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.285.12.1574","article-title":"Postexposure rabies prophylaxis in immunosuppressed patients","volume":"285","author":"Gibbons","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1093\/annonc\/mdy117_bb0145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.medmal.2008.06.031","article-title":"Yellow fever vaccination in non-immunocompetent patients","volume":"38","author":"Bruyand","year":"2008","journal-title":"Med Mal Infect"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-3062.2011.00686.x","article-title":"Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study","volume":"14","author":"Azevedo","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0155","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","article-title":"Severe measles in immunocompromised patients","volume":"267","author":"Kaplan","year":"1992","journal-title":"JAMA"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0160","first-page":"481","article-title":"Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia","volume":"82","author":"Volc","year":"2006","journal-title":"J Pediatr (Rio J)"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1086\/514661","article-title":"Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia","volume":"27","author":"Feldman","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1093\/annonc\/mdy117_bb0170","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJM198904063201403","article-title":"Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine","volume":"320","author":"Gershon","year":"1989","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0175","first-page":"Cd006505","article-title":"Vaccines for prophylaxis of viral infections in patients with hematological malignancies","author":"Cheuk","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3324\/haematol.2010.032664","article-title":"Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host","volume":"96","author":"de Lavallade","year":"2011","journal-title":"Haematologica"},{"issue":"10","key":"10.1093\/annonc\/mdy117_bb0185","first-page":"Cd008983","article-title":"Influenza vaccines in immunosuppressed adults with cancer","author":"Eliakim-Raz","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0190","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.3324\/haematol.2014.116772","article-title":"Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma","volume":"100","author":"Hahn","year":"2015","journal-title":"Haematologica"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3121\/cmr.3.4.214","article-title":"Efficacy of the influenza vaccine in patients with malignant lymphoma","volume":"3","author":"Mazza","year":"2005","journal-title":"Clin Med Res"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0200","first-page":"505","article-title":"Vaccination against influenza in multiple myeloma","volume":"97","author":"Musto","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0609.2003.00028.x","article-title":"Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma","volume":"70","author":"Rapezzi","year":"2003","journal-title":"Eur J Haematol"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1054\/bjoc.1999.1088","article-title":"Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma","volume":"82","author":"Robertson","year":"2000","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0215","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/annonc\/mdq728","article-title":"Response to influenza virus vaccination during chemotherapy in patients with breast cancer","volume":"22","author":"Meerveld-Eggink","year":"2011","journal-title":"Ann Oncol"},{"issue":"52","key":"10.1093\/annonc\/mdy117_bb0220","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2013.10.053","article-title":"Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours","volume":"31","author":"Wumkes","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJMc1505366","article-title":"Vaccine against pneumococcal pneumonia in adults","volume":"373","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0230","doi-asserted-by":"crossref","first-page":"e114966","DOI":"10.1371\/journal.pone.0114966","article-title":"Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients\u2013preliminary report","volume":"9","author":"Pasiarski","year":"2014","journal-title":"PLoS One"},{"issue":"13-14","key":"10.1093\/annonc\/mdy117_bb0235","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0264-410X(00)00409-6","article-title":"Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia","volume":"19","author":"Hartkamp","year":"2001","journal-title":"Vaccine"},{"issue":"11-12","key":"10.1093\/annonc\/mdy117_bb0240","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/00365540310016600","article-title":"Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer","volume":"35","author":"Reinhardt","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2141.2001.02882.x","article-title":"Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia","volume":"114","author":"Sinisalo","year":"2001","journal-title":"Br J Haematol"},{"issue":"7-8","key":"10.1093\/annonc\/mdy117_bb0250","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1345\/aph.1A277","article-title":"Immunization recommendations for adults with cancer","volume":"36","author":"Arrowood","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1093\/annonc\/mdy117_bb0255","unstructured":"Mitteilung der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut: Hinweise zu Impfungen f\u00fcr Patienten mit Immundefizienz. 02\/2017; 2005."},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0260","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.21203","article-title":"Epidemiology and outcomes of serious influenza-related infections in the cancer population","volume":"104","author":"Cooksley","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0265","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2003.06.008","article-title":"Influenza vaccination in elderly patients with advanced colorectal cancer","volume":"21","author":"Earle","year":"2003","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0270","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.vaccine.2006.10.015","article-title":"Impact of influenza vaccination on major cause-specific mortality","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"issue":"1-2","key":"10.1093\/annonc\/mdy117_bb0275","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjc.6690342","article-title":"Seroconversion after influenza vaccination in patients with lung cancer","volume":"80","author":"Anderson","year":"1999","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s005200000186","article-title":"Humoral immune response after vaccination against influenza in patients with breast cancer","volume":"9","author":"Brydak","year":"2001","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0285","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3109\/0284186X.2014.914243","article-title":"The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab","volume":"53","author":"Berglund","year":"2014","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0290","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/annonc\/mdr141","article-title":"Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and\/or targeted therapy: the VACANCE study","volume":"23","author":"Rousseau","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0295","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cncr.30468","article-title":"Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles","volume":"123","author":"Keam","year":"2017","journal-title":"Cancer"},{"issue":"29","key":"10.1093\/annonc\/mdy117_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000470159.45391.8f","article-title":"Effect of 23-valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization: a nationwide population-based cohort study","volume":"94","author":"Chiou","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1385\/MO:19:2:71","article-title":"Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae","volume":"19","author":"Nordoy","year":"2002","journal-title":"Med Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0310","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1200\/JCO.1985.3.5.718","article-title":"Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy","volume":"3","author":"Weitberg","year":"1985","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1093\/annonc\/mdy117_bb0315","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/08880010600907239","article-title":"Immunogenicity of hepatitis a vaccine in children with cancer","volume":"23","author":"K\u00f6ksal","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0320","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/vim.2012.0100","article-title":"Hepatitis A vaccination and immunological parameters in HIV-infected patients","volume":"26","author":"Kourkounti","year":"2013","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0325","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/jiv060","article-title":"Response to Hepatitis A vaccination in immunocompromised travelers","volume":"212","author":"Garcia Garrido","year":"2015","journal-title":"J Infect Dis"},{"issue":"Rr-01","key":"10.1093\/annonc\/mdy117_bb0330","first-page":"1","article-title":"Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"63","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0335","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3476(94)70012-5","article-title":"Response of immunocompromised children with solid tumors to a conjugate vaccine for Haemophilus influenzae type b","volume":"125","author":"Shenep","year":"1994","journal-title":"J Pediatr"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0340","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/107327481702400111","article-title":"Invasive Haemophilus influenzae infection in patients with cancer","volume":"24","author":"Singh","year":"2017","journal-title":"Cancer Control"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0345","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00364985","article-title":"Nosocomial bacterial and fungal meningitis in cancer patients","volume":"3","author":"Trupl","year":"1995","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0350","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3324\/haematol.2013.092460","article-title":"Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up","volume":"99","author":"Kristinsson","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0355","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMcp1314291","article-title":"Care of the asplenic patient","volume":"371","author":"Rubin","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0360","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00005373-200212000-00001","article-title":"Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively","volume":"53","author":"Shatz","year":"2002","journal-title":"J Trauma"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/14760584.4.1.27","article-title":"Vaccination considerations in the asplenic patient","volume":"4","author":"Shatz","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"17","key":"10.1093\/annonc\/mdy117_bb0370","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM196910232811703","article-title":"Functional asplenia in sickle-cell anemia","volume":"281","author":"Pearson","year":"1969","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1093\/annonc\/mdy117_bb0375","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/imj.13348","article-title":"Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand","volume":"47","author":"Kanhutu","year":"2017","journal-title":"Intern Med J"},{"key":"10.1093\/annonc\/mdy117_bb0380","unstructured":"Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee (VRBPAC) adult indication briefing document: Prevnar 13; 2011. www.fda.gov\/downloads\/advisorycommittees\/committeesmeetingmaterials\/bloodvaccinesandotherbiologics\/vaccinesandrelatedbiologicalproductsadvisorycomittee\/ucm279680.pdf."},{"issue":"18","key":"10.1093\/annonc\/mdy117_bb0385","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e3282887e91","article-title":"Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults","volume":"21","author":"Lesprit","year":"2007","journal-title":"AIDS"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0390","doi-asserted-by":"crossref","first-page":"e46133","DOI":"10.1371\/journal.pone.0046133","article-title":"Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients","volume":"7","author":"Tobudic","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0395","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/591537","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients","volume":"47","author":"Kumar","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0400","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.2146\/ajhp150270","article-title":"Vaccinations in asplenic adults","volume":"73","author":"Hammerquist","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0405","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/00365549209054649","article-title":"Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents","volume":"24","author":"Kristensen","year":"1992","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0410","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.vaccine.2010.11.034","article-title":"Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients","volume":"29","author":"Meerveld-Eggink","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0415","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10096-011-1378-8","article-title":"Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomy","volume":"31","author":"Mikoluc","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0420","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/M15-3005","article-title":"Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older: United States, 2016","volume":"164","author":"Kim","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40121-016-0107-0","article-title":"Meningococcal vaccinations","volume":"5","author":"Crum-Cianflone","year":"2016","journal-title":"Infect Dis Ther"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0430","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0435","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/IAI.72.1.332-337.2004","article-title":"Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals","volume":"72","author":"Balmer","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0440","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2334-10-219","article-title":"Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002","volume":"10","author":"Langley","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1093\/annonc\/mdy117_bb0445","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0450","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0609.2006.00693.x","article-title":"Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma","volume":"77","author":"Nishio","year":"2006","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0455","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/annonc\/mdl141","article-title":"High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication","volume":"17","author":"Cabanillas","year":"2006","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1093\/annonc\/mdy117_bb0460","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.4049\/jimmunol.1004095","article-title":"Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens","volume":"186","author":"Bedognetti","year":"2011","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"13","key":"10.1093\/annonc\/mdy117_bb0465","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1158\/1078-0432.CCR-11-0253","article-title":"Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination","volume":"17","author":"Mulder","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0470","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1001\/jamaoncol.2016.2437","article-title":"Seasonal influenza vaccination in patients with chronic lymphocytic leukemia treated with ibrutinib","volume":"2","author":"Sun","year":"2016","journal-title":"JAMA Oncol"},{"issue":"268","key":"10.1093\/annonc\/mdy117_bb0475","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0480","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ki.2010.269","article-title":"Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses","volume":"78","author":"Struijk","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0485","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(12)70006-2","article-title":"Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial","volume":"13","author":"Madan","year":"2012","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1093\/annonc\/mdy117_bb0490","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0495","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bmt.1703228","article-title":"Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines","volume":"28","author":"Nordoy","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1093\/annonc\/mdy117_bb0500","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1703239","article-title":"Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients","volume":"28","author":"Gandhi","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0505","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/313663","article-title":"Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients","volume":"30","author":"Pauksen","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0510","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1093\/annonc\/mdy117_bb0515","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3324\/haematol.2011.041913","article-title":"Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients","volume":"96","author":"Ljungman","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0520","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/425004","article-title":"Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy","volume":"39","author":"Nichols","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0525","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3109\/10428194.2012.742524","article-title":"Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant","volume":"54","author":"Villa","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1093\/annonc\/mdy117_bb0530","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2011.02.004","article-title":"Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation","volume":"17","author":"Gueller","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1093\/annonc\/mdy117_bb0535","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.vaccine.2010.12.113","article-title":"The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A\/California\/7\/2009 (H1N1)v-like virus vaccine during the 2009 pandemic","volume":"29","author":"Engelhard","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0540","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4161\/hv.27998","volume":"10","author":"Juergens","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"15","key":"10.1093\/annonc\/mdy117_bb0545","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2010.01.025","article-title":"Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial","volume":"28","author":"Cordonnier","year":"2010","journal-title":"Vaccine"},{"issue":"51","key":"10.1093\/annonc\/mdy117_bb0550","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1016\/j.vaccine.2007.10.008","article-title":"Vaccination responses and lymphocyte subsets after autologous stem cell transplantation","volume":"25","author":"van der Velden","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0555","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbmt.2004.12.330","article-title":"Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation","volume":"11","author":"Antin","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1093\/annonc\/mdy117_bb0560","first-page":"1582","article-title":"Development of functional Haemophilus influenzae type b antibodies after vaccination","volume":"90","author":"van der Velden","year":"2005","journal-title":"Haematologica"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0565","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1700843","article-title":"Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT)","volume":"20","author":"Chan","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0570","first-page":"1149","article-title":"Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation","volume":"17","author":"Molrine","year":"1996","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0575","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/511641","article-title":"Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1093\/annonc\/mdy117_bb0580","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0585","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.bmt.1701289","article-title":"Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients","volume":"22","author":"Hammarstrom","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0590","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.bmt.1704678","article-title":"Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients","volume":"34","author":"Ljungman","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0595","first-page":"295","article-title":"Immune response to polio vaccination in bone marrow transplant recipients","volume":"8","author":"Engelhard","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0600","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bbmt.2009.07.018","article-title":"Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation","volume":"15","author":"Small","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdy117_bb0605","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/infdis\/jit560","article-title":"Immune responses to pertussis vaccines and disease","volume":"209","author":"Edwards","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0610","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2011.08913.x","article-title":"Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation","volume":"156","author":"Inaba","year":"2012","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1093\/annonc\/mdy117_bb0615","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2006-04-006981","article-title":"Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants","volume":"108","author":"Jaffe","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1093\/annonc\/mdy117_bb0620","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbmt.2008.08.007","article-title":"HB Vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection","volume":"14","author":"Onozawa","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1093\/annonc\/mdy117_bb0625","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/tid.12295","article-title":"Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation","volume":"16","author":"Sasadeusz","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1093\/annonc\/mdy117_bb0630","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bmt.1704476","article-title":"Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants","volume":"33","author":"Spoulou","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0635","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","article-title":"Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine","volume":"159","author":"Ljungman","year":"1989","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1093\/annonc\/mdy117_bb0640","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0645","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-3062.2011.00655.x","article-title":"Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population","volume":"13","author":"Rogers","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0650","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2015.12.025","article-title":"Safety of live attenuated high-titer varicella-zoster virus vaccine in pediatric allogeneic hematopoietic stem cell transplantation recipients","volume":"22","author":"Aoki","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0655","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","article-title":"Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients","volume":"20","author":"Issa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1093\/annonc\/mdy117_bb0660","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1086\/514077","article-title":"Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine","volume":"176","author":"Redman","year":"1997","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1093\/annonc\/mdy117_bb0665","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0609.2004.00216.x","article-title":"Immunogenicity of a two-dose regime of varicella vaccine in children with cancers","volume":"72","author":"Leung","year":"2004","journal-title":"Eur J Haematol"},{"issue":"11","key":"10.1093\/annonc\/mdy117_bb0670","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1093\/annonc\/mdy117_bb0675","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1093\/annonc\/mdy117_bb0680","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2010.04.015","article-title":"A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients","volume":"56","author":"Tung","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"7-8","key":"10.1093\/annonc\/mdy117_bb0685","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0264-410X(98)00272-2","article-title":"Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients","volume":"17","author":"Dengler","year":"1999","journal-title":"Vaccine"},{"issue":"19","key":"10.1093\/annonc\/mdy117_bb0690","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdy117_bb0695","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann Hematol"},{"issue":"14","key":"10.1093\/annonc\/mdy117_bb0700","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.vaccine.2015.02.029","article-title":"Influenza vaccination perception and coverage among patients with malignant disease","volume":"33","author":"Poeppl","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1093\/annonc\/mdy117_bb0705","first-page":"511","article-title":"Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members","volume":"18","author":"Urun","year":"2013","journal-title":"J Buon"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419348975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419348975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/29\/6\/1354\/25057255\/mdy117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T17:40:57Z","timestamp":1661017257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419348975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":140,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0923753419348975"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdy117","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}